ArticleFrontiers in oncology2022

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices.

Stephen V Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.